MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

News   Apr 30, 2018 | Original story from Rockefeller University Press

 
MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

Compared with control animals (left), the spinal cords of rats treated with bortezomib (center) contain increased numbers of activated astrocytes (green) that cause neuropathic pain. Bortezomib's effects are prevented by the multiple sclerosis drug fingolimod (right), which inhibits the sphingolipid metabolite receptor S1PR1. Credit: Stockstill et al., 2018

 
 
 

RELATED ARTICLES

SpiderMass Device to Speed Up Cancer Surgery

News

A new proteomic assay called SpiderMass which heats water in human tissue to enable ion analysis will allow doctors to speed up cancer surgery by locating tumor biomarkers more quickly.

READ MORE

Researchers Identify Gene That Helps Prevent Brain Disease

News

Protein ‘proofreading’ errors lead to neurodegenerative disease.

READ MORE

Leg Exercise is Critical to Brain and Nervous System Health

News

New research shows that using the legs, particularly in weight-bearing exercise, sends signals to the brain that are vital for the production of healthy neural cells.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy